Systemic Lupus Erythematosus, Fifth Edition George Tsokos, Jill P. Buyon, Takao Koike, Robert G. Lahita
Publisher: Academic Press
SLE 2012 : 5th International Conference on Software Language Engineering. 673–696, Elsevier, London, UK, 5th edition, 2011. Catatonia in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Based on suspicion of neuropsychiatric systemic lupus erythematosus (SLE) (because of positive antinuclear factors and neurological symptoms), immuno-suppressive therapy was initiated. Systemic Lupus Erythematosus, Fifth Edition. The electronic version of this article is the complete one and can be found online at: http://www.capmh.com/content/5/1/15 . Systemic.Lupus.Erythematosus.Fifth.Edition..pdf. Belimumab, a human monoclonal antibody that inhibits B-cell activating factor (BAFF), has demonstrated efficacy in . Novel agents for the treatment of immune-mediated diseases such as systemic lupus erythematosus (SLE) have been increasingly used as an alternative to or in combination with conventional therapies. Systemic lupus erythematosus (also called lupus or SLE) is a disease in which a person's immune system attacks and injures the body's own organs and tissues. The electronic version of this article is the complete one and can be found online at: http://www.translational-medicine.com/content/10/1/170 Systemic Lupus Erythematosus (SLE) is the prototype for systemic autoimmune disease.